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Background: The incidence of postoperative nausea and vomiting (PONV) is 50 to 79% after neurosurgery. Our
study is designed to evaluate the efficacy of pericardium 6 (P6; also known as Neiguan) acupoint stimulation versus
placebo, and versus routine antiemetic for the prevention of PONV after craniotomy, as well as to compare the
efficacy of invasive acupuncture with non-invasive transcutaneous electrical nerve stimulation (TENS) on P6.
Methods/design: This is a single-center, prospective, double-blind, five-arm, parallel-group, randomized controlled
trial (RCT). All groups will be given routine intravenous ondansetron 8 mg administered before skin closure. Upon
regaining consciousness from general anaesthesia, patients will receive one of five interventions: 1) P6 acupuncture
bilaterally for 30 minutes, stimulated every 10 minutes to keep de qi sensation; 2) sham acupuncture bilaterally for
30 minutes with no stimulation; 3) P6 stimulation via active TENS electrodes bilaterally for 30 minutes, with
stimulation frequency and intensity set to when de qi sensation is felt; 4) sham P6 stimulation via inactive TENS
electrode bilaterally for 30 minutes; and 5) usual practice of pharmacological emesis prevention. The incidence of
postoperative vomiting during the first 24 hours is the main outcome. Secondary outcomes include: complete
response rate, severity of nausea, total rescue metoclopramide dose used and patient satisfaction with PONV
management.
Discussion: The results from this study could potentially confirm that P6 acupoint stimulation is an effective
adjunct to standard antiemetic drug therapy for the prevention of PONV in patients undergoing craniotomy. Our
study may also confirm that conventional acupuncture is more effective than TENS.
Trial registration: This study is registered with the Chinese Clinical Trial Registry: ChiCTR-TRC-13003026.
Keywords: Acupoint stimulation, Nausea, Vomiting, CraniotomyBackground
As a common complication of anesthesia and surgery,
postoperative nausea and vomiting (PONV) remains pro-
blematic despite use of antiemetics. PONV delays the pa-
tient’s recovery from anesthesia, extends their hospital
stay and increases overall healthcare costs [1]. Although
PONV is rarely fatal, the physical act of vomiting may in-
crease cerebral intravascular pressure or intracranial pres-
sure, which may lead to cause severe consequences in* Correspondence: zhenjiuhuaxi@163.com
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reproduction in any medium, provided the orpatients who have undergone craniotomy. Studies have
reported an average incidence of PONV of up to 38.3%
following common surgeries [2], while in patients specific-
ally undergoing neurosurgery, the incidence is as great as
50 to 79% [3,4]. There are no significant differences in the
frequency of nausea based on the craniotomy location [5].
PONV has a multi-factor etiology and the mechanism is
complex. Currently, pharmacological prophylaxis is widely
used in clinical practice, and the most commonly used
prophylactic antiemetics include serotonin (5-HT3) re-
ceptor antagonists often in combination with either
droperidol or dexamethasone [6,7]. Although droperidolThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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rhythmia or QT prolongation [8]. At present, no therapy
is absolutely effective at preventing PONV.
Due to the limited efficacy and many side effects of drug
therapy, various non-pharmacological techniques have
been used in clinical practice. These therapies include
acupuncture, acupressure, transcutaneous electrical nerve
stimulation (TENS), electro-acupuncture, and others. Ear-
ly in 2006, the American Society of PeriAnesthesia Nurses
(ASPAN) recommended pericardium 6 (P6; also known as
Neiguan) acupoint stimulation (Class IIb, Level A) as a
complementary intervention for PONV prophylaxis [9].
According to the theory of traditional Chinese medicine
(TCM), performing surgery breaks the balanced state of
the human body and disturbs the movement of both qi
and blood. When this happens, stomach qi will reverse its
direction and go upward, causing nausea and vomiting.
The main principle of treatment in this case is to regulate
the function of the stomach to avoid the adverse flow
of qi. P6 is an acupuncture point in the meridian named
Jueyin Pericardium Meridian of Hand. It is both the Luo-
connecting point (the point where a collateral starts to
connect a definite pair of Yin and Yang meridians, which
are externally-internally related) and the eight confluent
point (the point connecting the eight extra meridians with
the twelve primary meridians). One of P6’s main functions
is to regulate the function of the stomach to avoid the
adverse flow of qi, thus it is an effective acupoint for
preventing nausea and vomiting.
Many recent studies have supported the efficacy of P6
acupoint stimulation for preventing PONV [10-12], with
very few gaining a negative result [13,14]. The various
ways to stimulate the P6 acupoint include laser, electrical,
transcutaneous electrical and manual stimulation. Few
studies have compared the efficacy of invasive methods
with non-invasive methods. Thus, the optimal method of
stimulation has not been determined due to lack of evi-
dence. Although there is a great amount of research
concerning P6 acupoint stimulation for preventing PONV,
only two studies focus on the role of P6 acupoint sti-
mulation in postoperative patients following craniotomy
[15,16]. Therefore, we designed a single-center, prospect-
ive, double-blind, five-arm, parallel-group, randomized
controlled trial (RCT) to evaluate the efficacy of P6 acu-
point stimulation as a non-pharmacological prophylaxis
for PONV.
The primary objective of this study is to evaluate the ef-
ficacy of P6 acupoint stimulation versus placebo, and ver-
sus routine antiemetic for the prevention of PONV in
patients undergoing craniotomy under general anesthesia.
The secondary study objective is to compare the efficacy
of invasive acupuncture with non-invasive TENS on P6.
We hypothesize that a significantly greater percentage
of patients will not vomit in the subsequent 24 hoursfollowing craniotomy in the acupoint stimulation groups.
Additionally, we expect that the severity of nausea will be




This is a single-center, prospective, double-blind, five-arm,
parallel-group, RCT. The trial protocol strictly follows the
principles of the Declaration of Helsinki (version Seoul,
2008) and approval has been obtained from Si-chuan
University's Ethics and Research Committee. Participants
have been and will continue to be recruited from the West
China Hospital of Si-chuan University (WCHSU) from
January 2013 to October 2013 (Figure 1). All participants
are required to give written informed consent.
Patient population and setting
A total of 300 Chinese patients undergoing craniotomy
will be sequentially recruited at the WCHSU after fulfill-
ing the eligibility criteria and signing the informed con-
sent. A clinical assistant with institutional review board
training will be in charge of patient enrollment.
Eligibility criteria
Inclusion criteria
Patients who fulfill the following conditions will be in-
cluded: 1) scheduled for neurosurgery requiring opening
of the cranium and dura; 2) aged between 18 and 70 years
old; 3) American Society of Anesthesiologists (ASA) phys-
ical status classification of I or II; 4) undergoing general
anesthesia; 5) no history of PONV or motion sickness; 6)
no use of antiemetic 24 hours before surgery; 7) willing to
participate; 8) no experience with acupuncture therapies;
and 9) signed an informed consent form.
Exclusion criteria
Participants that meet any of the following criteria will
be excluded: 1) nausea or vomiting 24 hours before sur-
gery; 2) pregnant or lactating women; 3) drug or alcohol
abusers; 4) recipients of chemotherapy or radiation ther-
apy during the previous 7 days; 5) cardiac pacemaker; 6)
menstruating phase of the menstrual cycle; 7) refusal to
accept acupuncture and TENS treatment; 8) mental
disorder; 9) history of epilepsy and still taking an an-
tiepileptic medicine; 10) unconscious before the surgery;
11) cannot normally communicate; 12) undergoing ven-
tricle or brainstem surgery; 13) cerebral perfusion pres-
sure (CPP) of less than 50 mmHg or greater than 150
mmHg; 14) poorly controlled diabetes mellitus (fasting
plasma glucose greater than 12 mmol/L); 15) bleeding
disorders (hemophilia or afibrinogenemia); and 16) ser-
ious systemic disease (AIDS or sepsis).
Figure 1 Trial flow chart. If a patient can not complete the study due to death, re-operation, unconsciousness or cognitive impairment, the
patient will be considered a lost case and recorded as an occurrence of PONV. PONV, postoperative nausea and vomiting; TENS, transcutaneous
electrical nerve stimulation.
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The randomization sequence will be computer-generated
by independent research staff using software called Pack-
age for Encyclopaedia Medical Statistics 3.1 (PEMS 3.1).
Stratification will not be used in this trial. After ran-
domization, group assignments will be concealed in light-
proof and sealed envelopes. The included participants will
be randomly enrolled by sealed envelope and assigned to
the acupuncture group, sham-acupuncture control group,
TENS group, placebo-TENS control group and usual
treatment group, using a 1:1:1:1:1 ratio. Patient allocation
will be performed by a clinical assistant, who will be
trained in institutional review board policies. All study
personnel including the outcome assessors, study partici-
pants, data analyst and care providers will be blinded to
group assignments.
Interventions
In this trial, we will use both invasive and non-invasive
methods to stimulate the P6 acupoint as an adjunct to
routine antiemetic drug therapy for the prevention of nau-
sea and vomiting in patients undergoing craniotomy. The
routine antiemetic treatment for high-risk patients at the
WCHSU is a single intravenous dose of 8 mg ondansetron
administered before skin closure. Therefore, neither dexa-
methasone nor droperidol will be used in our study.
To date, the optimal timing of acustimulation for
preventing PONV has not been determined. In our study,
the intervention is started right after the patient regainsconsciousness from anesthesia for two reasons. First, in
the TCM theory, it is important to locate the right acu-
point with the de qi sensation (the sensation of numbness,
heaviness or distention associated with correct identifica-
tion of an acupuncture point) to enhance efficacy, and this
cannot be accomplished when the patient is unconscious.
Second, a recent RCT shows that postoperative acus-
timulation is more effective in reducing PONV [17].
In preparation for surgery, all patients will receive a
standard anesthesia and analgesia regimen specific to
neurosurgical procedures. They will fast for 8 hours before
general anesthesia. Standard monitors will be used to rec-
ord patients' electrocardiogram, pulse oximetry, invasive
arterial blood pressure and end tidal CO2. Induction of
anesthesia will be achieved with midazolam 0.05 mg/kg,
sufentanil 0.3 μg/kg, atracurium 0.15 mg/kg and propofol
2 mg/kg. When endotracheal intubation and gastrointes-
tinal decompression with either an orogastric or nasogas-
tric tube are undertaken, the anesthesia will be maintained
with 50% nitrous oxide and 3% sevoflurane, and intermit-
tent sufentanil 0.2 μg/kg and atracurium 0.1 mg/kg. Intra-
venous ondansetron 8 mg is administered as a routine
antiemetic treatment for each patient before skin closure.
Fentanyl 25 to 50 μg intravenous boluses are used as
needed for postoperative, patient-controlled intravenous
analgesia (PCIA). After surgery, patients will be continu-
ally monitored in the post-anesthesia care unit (PACU).
Tracheal extubation will be undertaken when patients
regain consciousness from anesthesia. Intramuscular me-
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antiemetic and administered at the patient’s request.
When the patients regain consciousness from anesthesia
and are able to communicate, the intervention will begin.
All participants in our study will receive the intervention
only once. In preparation for acustimulation, the patient
will be placed in the best posture for P6 acupuncture, with
their forearms fully exposed and with their palms facing
upward. A fourth-year acupuncture resident will locate
the P6 acupoint bilaterally (Figure 2) and perform the in-
terventions specified in Table 1. P6 is an important acu-
puncture point in the Jueyin Pericardium Meridian of
Hand. The location of P6 is 2 cun (a cun is a measurement
used in acupuncture and is equivalent to the width of the
distal interphalangeal joint of the first finger) above the
transverse crease of the wrist, between the tendons of
palmaris longus and flexor carpi radialis.
For the acupuncture group (group A), after skin
cleaning with 75% alcohol swab, sterile and disposa-
ble stainless steel needles (0.25 × 25 mm, Wuxi Jiajian,
Jiangsu, China) are quickly and perpendicularly inserted
into the skin at P6 acupoints bilaterally to a depth of 20
mm. In this group, downward pressure and upward lifting
combined with twirling the needle will be used to achieve
de qi sensation. The needles will be kept in place for 30
minutes and manipulated manually every 10 minutes to
maintain the de qi sensation. When the treatment time is
over, all needles will be carefully taken out and the punc-
ture sites will be covered with sterile swabs to avoid
bleeding.
For the sham-acupuncture control group (group SA),
sham points are used, which are superficial, non-
acupoints on the radial side of each wrist, 15 mm away
from each P6 acupoint (Figure 2). After skin cleaning withFigure 2 Location of P6 acupoint and sham acupoint.75% alcohol swab, sterile and disposable stainless steel
needles (0.25 × 25 mm, Wuxi Jiajian, Jiangsu, China) are
quickly and perpendicularly inserted into the skin at sham
acupoints bilaterally to a depth of 5 mm. The de qi sensa-
tion is not required in this group. The needles will be
retained for 30 minutes as with the group A, but will not
be stimulated or manipulated for the duration. After 30
minutes, the same method will be used to take out the
needles as in the group A.
For the TENS group (group T), the patients' forearms
are cleaned with 75% alcohol swabs and self-adhesive elec-
trodes are placed over P6 acupoints bilaterally. SDZ-V
nerve and muscle stimulators (Hwato, Jiangsu, China) are
used for TENS (Figure 3). The treatment time is also 30
minutes, using dilatational wave. The stimulation fre-
quency is set on 2 to 100 hertz and intensity varies until
the patients feel the de qi sensation continuously. The
screen on each stimulator is covered with 6 × 8 cm black
tape so that no one will see the screen and know whether
the stimulator is on or off. When the treatment time is
complete, all self-adhesive electrodes will be removed.
For the placebo-TENS control group (group PT), pa-
tients have self-adhesive electrodes placed over P6
acupoints bilaterally, and are connected to the SDZ-V
nerve and muscle stimulators for 30 minutes. However,
as a placebo control group, the stimulators will not be
turned on and there will be no electrical stimulation
during the treatment. In order to blind patients in this
group, each participant will be informed that special
acupoint stimulation is used in the treatment which can-
not be felt by human sensory perception. After 30 mi-
nutes, all self-adhesive electrodes will be removed as in
the group T.
For the usual treatment group (group U), no interven-
tions are undertaken. Patients in this group will be ob-
served by the researchers as a blank control, which will
provide a baseline postoperative vomiting rate and nau-
sea score in this study using the same drug prophylaxis.
Outcome measurement
In our study, outcomes are collected based on previously
designed PONV studies [18]. The whole study period
covers 24 hours after the surgery. A separate research
nurse, who is not involved in the management of patients,
will record anesthesia time, surgery time, endotracheal in-
tubation time, patient demographics and preoperative data
for each patient. Demographic and preoperative data will
include: age, gender, race, weight, height, acupuncture ex-
perience, smoking history and CPP. Another blinded ob-
server will record the postoperative data, which will
include administration of a rescue antiemetic, patient sat-
isfaction with PONV management, and episodes of
vomiting or nausea at 2 hours, 6 hours and 24 hours post-
operatively. The physicians will record the use time and
Table 1 Details of interventions
Group names Acupoints De qi
sensation
Interventions
Acupuncture group P6 (Neiguan)
bilaterally
Yes P6 at both sides is punctured perpendicularly to a depth of 20 mm. Needles are retained for 30






No The sham point is punctured to a perpendicular depth of 5 mm bilaterally. Needles are retained
for 30 minutes and no stimulation is performed during this duration.
(group SA)
TENS group P6 (Neiguan)
bilaterally
Yes P6 acupoint at both sides is stimulated by active self-adhesive electrodes for 30 minutes. The
stimulation frequency is set on 2 to 100 hertz and intensity varies until the patients continue to











TENS, transcutaneous electrical nerve stimulation.
Lv et al. Trials 2013, 14:153 Page 5 of 7
http://www.trialsjournal.com/content/14/1/153dosage of rescue antiemetic for each patient when they re-
quest rescue therapy, and the records will be handed over
to the observer for assessment. Nausea is a subjective sen-
sation which should be evaluated by the patient, not by
the observer. Thus, the observer will request the patients
to evaluate their nausea score using a standard visual
analogue scale (VAS) (0, no nausea at all; 10, worstFigure 3 The SDZ-V nerve and muscle stimulator (Hwato,
Jiangsu, China) and self-adhesive electrodes.imaginable nausea). Vomiting, which is defined as the
ejection of contents of the stomach through the mouth,
will be reported by the patients and assessed by this
blinded observer. Patient satisfaction is not an easy con-
cept to measure. Until recently, there has been no consen-
sus on how to measure this concept. Since satisfaction is
multi-faceted and subjective, a questionnaire cannot cover
every aspect of a patient’s concerns. Therefore, in this
study, patients will be asked about satisfaction with their
PONV treatment at 24 hours postoperatively using an-
other 0 (very dissatisfied) to 10 (very satisfied) scale.
The incidence of postoperative vomiting within 24
hours after craniotomy across the five groups is the main
outcome we are studying. The secondary outcomes are: 1)
proportion of participants with a complete response (no
vomiting, no nausea, no rescue antiemetic) during 0 to 2
hours, 2 to 6 hours, 6 to 24 hours and 0 to 24 hours after
craniotomy under general anesthesia; 2) assessment of
nausea score (severity of nausea) during 0 to 2 hours, 2 to
6 hours and 6 to 24 hours after craniotomy under general
anesthesia; 3) assessment of total rescue antiemetic dosage
during 0 to 24 hours after craniotomy under general
anesthesia; and 4) assessment of satisfaction score (patient
satisfaction with PONV management) at 24 hours
postoperatively.
Sample size calculation and statistical analysis
A German prospective observational study published in
2011 demonstrated an overall incidence of PONV in 47%
of patients after craniotomy under general anesthesia [4].
The sample size is determined by using PEMS 3.1 with
α = 0.05 (two-sided) and β = 0.1 (90% power). In order to
demonstrate a 30% absolute reduction in the incidence of
PONV, the sample size will be 49 patients for each group.
Considering the potential loss and attrition, 60 patients
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If a patient can not complete the study due to death, re-
operation, unconsciousness or cognitive impairment, the
patient will be considered a lost case and recorded as an
occurrence of PONV.
All data will be analyzed by a blinded statistician using
PEMS 3.1 at a separate location from the WCHSU. The
intention-to-treat principal will be used in the data ana-
lysis. Baseline data will be collected and compared first.
Different statistics are presented differently, for example,
continuous data is presented as mean (± standard devi-
ation). Chi-square test is used to compare the incidence
of postoperative vomiting, complete response rate, sex
difference and other nominal data. Conversely, the
Kruskal-Wallis test is used to compare the nausea score,
satisfaction score and antiemetic dosage. Additionally, the
Nemenyi test and Scheffé’s method are used for multiple
comparisons between groups. A P value <0.05 is consid-
ered statistically significant.
Discussion
This study could potentially confirm that P6 acupoint
stimulation is an effective adjunct to the standard
antiemetic drug therapy for the prevention of PONV in
patients undergoing craniotomy. Our study may also con-
firm that conventional acupuncture is more effective than
TENS. The reason why we chose 2 hours, 6 hours and 24
hours postoperatively as the observation points are be-
cause: 1) volatile anesthetics may be the main cause for
early (within 2 hours after the surgery) but not delayed
postoperative nausea and vomiting [19]; 2) the half-life of
ondansetron is approximately 6 hours based on pharma-
cokinetics [20]; and 3) PONV is defined as vomiting and/
or nausea occurring within 24 hours after surgery [21].
Previous studies have not indicated whether the dur-
ation of P6 acupoint stimulation alters its effect on
PONV. From our point of view, a long duration of acu-
point stimulation will increase patients’ discomfort and
pain, especially for those in the acupuncture group.
However, if the stimulation time is too short, the thera-
peutic effect of acupuncture on PONV will be uncertain.
In our study, we believe the most reasonable duration of
P6 acupoint stimulation is 30 minutes, which is the
common acupuncture treatment time at WCHSU.
The most difficult part in this research will be to blind
the patients in different treatment groups. Recruiting pa-
tients with no experience of any kind of acupuncture ther-
apies is part of the basic method, since patients who have
not experienced de qi sensation are easier to blind. Fur-
thermore, different sham groups are set up according to
different stimulation methods. Acupuncture is an invasive
method and we chose to blind the patients by superficially
acupuncturing the sham point, which has been commonly
used as an invasive control condition in several studies[22-24]. TENS is used as the non-invasive method and we
chose to blind the patients by using inactive self-adhesive
electrodes. In order to better blind the patients using the
non-invasive methods, each participant will be informed
that special acupoint stimulation is used in the treatment
which cannot be felt by human sensory perception.
Trial status
This trial is currently recruiting participants.
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